Evidence strength for the context described on this page.
PEPTIDE ATLAS / SEXUAL & REPRODUCTIVE / KISSPEPTIN-10
InvestigationalEarly human
Kisspeptin-10
ALSO KNOWN ASKP-10
A reproductive-signaling peptide under study—not a consumer libido or fertility protocol.
01CATEGORYSexual & reproductive
02REGULATORY STATUSInvestigational
03COMMON ROUTEIntravenous or subcutaneous in research; subcutaneous in clinic marketing
04REVIEW STANDARDProduct, indication and evidence
HOW TO USE THIS PAGE
Read the profile in the order that protects the decision.
- 01Verify what it is
Confirm the exact molecule, route, regulatory lane and actual human evidence.
- 02Read the evidence limits
Unsupported claims, contraindications and uncertainty come before any protocol.
- 03Build the monitoring plan
Define the target, baseline checks, reassessment point and stop rules with a qualified clinician.
This peptide does not have an FDA-approved product or dose for the claims described here. Research dosing and vendor protocols are not consumer prescribing guidance.
RESEARCH PASSPORT
The five facts to know first.
REVIEWED
JULY 2026
Status is product-, formulation- and indication-specific.
Public education does not establish a personal treatment plan.
Official labels, regulators, trials and indexed literature where available.
Peptide hormones, growth factors and related substances may be prohibited.
Check Global DRO ↗OVERVIEW
What Kisspeptin-10 is.
A short active fragment of kisspeptin that stimulates the hypothalamic reproductive axis. Clinical research includes fertility, hormone release and sexual/brain-response questions.
HOW IT IS THOUGHT TO WORK
Activates KISS1R, stimulating GnRH and downstream LH/FSH signaling when the reproductive axis is responsive.
EFFECTS & EVIDENCE
What the evidence supports—and what it does not.
- Can trigger reproductive-hormone signaling in controlled research
- Investigational fertility applications
- General libido enhancement
- Treatment of infertility outside specialist protocols
- Safe chronic use
- An established male or female wellness dose
Evidence grade: Early human. For an approved drug, “high” refers only to its labeled indication—not every off-label or wellness claim.
CLINICAL CONTEXT
The decision is individual.
Research interest does not establish an approved treatment, a safe personal regimen or reliable product quality. Discuss established alternatives with a qualified clinician.
Identify the outcome, formulation and population actually studied.
Review benefits, uncertainty, contraindications and better-studied alternatives.
A treatment decision needs a responsible clinician, monitoring and a review date.
This public guide does not provide a dosing, injection or self-treatment protocol. Bring the source links and the exact product into a licensed clinical consultation.
MONITORING
What should be tracked.
- LH, FSH and sex-steroid response
- Ovulation or assisted-reproduction outcomes
- Ovarian response and specialist safety monitoring
SAFETY
Risks, red flags and reasons to avoid it.
- Hormonal overstimulation
- Unknown long-term effects
- Immunogenicity and impurities in compounded products
- Potential interference with fertility protocols
- Self-treatment
- Pregnancy outside research
- Use without reproductive-endocrinology oversight
- Unverified compounded product
Stop and seek careGet urgent medical help for trouble breathing, facial or throat swelling, chest pain, fainting, severe persistent abdominal pain, neurologic changes, severe hypoglycemia, uncontrolled vomiting or a prolonged painful erection.
CLINICIAN VISIT CHECKLIST
Six questions worth bringing with you.
Molecule or analog, salt, concentration, route, manufacturer or compounder, lot and beyond-use date.
Name the diagnosis or target, how it will be measured and the realistic time to reassess.
Ask how it compares with FDA-approved, lower-risk or better-studied alternatives.
Label, human trial, specialty guideline or clinic convention—and whether that route and formulation match.
Baseline checks, follow-up measures, interactions, pregnancy considerations and symptoms that mean stop.
Pharmacy license, prescription, identity/potency testing, sterility controls and who handles a product complaint.
Do not improvise reconstitution or convert “units” without the exact concentration. Mixing, storage and beyond-use instructions are product-specific; confirm them with the dispensing pharmacy.
SOURCES & RESEARCH LINKS
Read the record yourself.
We prioritize official prescribing information, FDA regulatory material, registered trials and indexed biomedical literature. A source supports the specific statement beside it—not every claim made about the molecule.
PRODUCTS & TREATMENT ACCESS
There is no product we can responsibly recommend.
Clinical research and limited unapproved marketing; no FDA-approved kisspeptin-10 drug.
A peptide that moves a hormone marker can be biologically active without being a proven fertility or desire treatment.
Evidence before affiliate revenue.
We do not rank or sell unapproved research peptides. Use the Atlas to discuss safer, evidence-backed alternatives with a qualified clinician.
Explore evidence-backed options →NEXT STEP